The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M. J., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,406
let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells
Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.054 · Cited by 1,910
Self-citationPonti, D., Costa, A., Zaffaroni, N., Pratesi, G., Petrangolini, G., Coradini, D., Pilotti, S., Pierotti, M. A., & Daidone, M. G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0626 · Cited by 1,723
Jordan, C. T., Guzman, M. L., & Noble, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra061808 · Cited by 1,702
miRNAs, Cancer, and Stem Cell Division
Croce, C. M., & Calin, G. A. (2005) · Cell · doi:10.1016/j.cell.2005.06.036 · Cited by 1,329
Cancer Stem Cells: Models and Concepts
Dalerba, P., Cho, R. W., & Clarke, M. F. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.062105.204854 · Cited by 1,274
Cancer stem cells: mirage or reality?
Gupta, P. B., Chaffer, C. L., & Weinberg, R. A. (2009) · Nature Medicine · doi:10.1038/nm0909-1010 · Cited by 979
Glinsky, G. V., Berezovska, O., & Glinskii, A. B. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23412 · Cited by 916
Sumo, ubiquitin's mysterious cousin
Müller, S., Hoege, C., Pyrowolakis, G., & Jentsch, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056591 · Cited by 764
MicroRNAs as Oncogenes and Tumor Suppressors
Chen, C.-Z. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058190 · Cited by 758
MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
Ji, Q., Hao, X., Zhang, M., Tang, W., Yang, M., Li, L., Xiang, D., DeSano, J. T., Bommer, G. T., Fan, D., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006816 · Cited by 689
Gilmore, A. P. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401723 · Cited by 597
Role of Integrins in Cancer: Survey of Expression Patterns
Mizejewski, G. J. (1999) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-122.x · Cited by 451
Recent advances in cancer stem cells
Cho, R. W., & Clarke, M. F. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.017 · Cited by 227
A role for Ubc9 in tumorigenesis
Mo, Y.-Y., Yu, Y., Theodosiou, E., Rachel Ee, P. L., & Beck, W. T. (2005) · Oncogene · doi:10.1038/sj.onc.1208210 · Cited by 183
Cancer Stem Cells and Tumor Metastasis: First Steps into Uncharted Territory
Dalerba, P., & Clarke, M. F. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.012 · Cited by 179
Cancer stem cells and oncology therapeutics
Al‐Hajj, M. (2006) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328011a8d6 · Cited by 149
MicroRNA-mediated Regulation of Ubc9 Expression in Cancer Cells
Wu, F., Zhu, S., Ding, Y., Beck, W. T., & Mo, Y. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0820 · Cited by 123
Signalling mechanisms of anoikis.
Zhan, M., Zhao, H., & Han, Z. (2004) · PubMed · doi:10.14670/hh-19.973 · Cited by 107
Integrins in mammary-stem-cell biology and breast-cancer progression – a role in cancer stem cells?
Pontier, S. M., & Muller, W. J. (2008) · Journal of Cell Science · doi:10.1242/jcs.040394 · Cited by 82
Post‐translational modification of POU domain transcription factor Oct‐4 by SUMO‐1
Zhang, Z., Liao, B., Xu, M., & Jin, Y. (2007) · The FASEB Journal · doi:10.1096/fj.06-6914com · Cited by 72
SUMOylation of Tr2 orphan receptor involves Pml and fine-tunes Oct4 expression in stem cells
Park, S. W., Hu, X., Gupta, P. K., Lin, Y.-P., Ha, S. G., & Wei, L. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1185 · Cited by 49
Developmental regulation of Ubc9 in the rat nervous system.
Watanabe, M., Takahashi, K., Tomizawa, K., Mizusawa, H., & Takahashi, H. (2008) · Acta Biochimica Polonica · doi:10.18388/abp.2008_3027 · Cited by 37
Cited by
microRNAs in cancer management
Kong, Y. W., Ferland-McCollough, D., Jackson, T. J., & Bushell, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70073-6 · Cited by 734
Zhang, Y., Xie, R.-L., Croce, C. M., Stein, J. L., Lian, J. B., van Wijnen, A. J., & Stein, G. S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018493108 · Cited by 423
A microRNA Signature Associated with Early Recurrence in Breast Cancer
Pérez-Rivas, L. G., Jerez, J. M., Carmona, R., de Luque, V., Vicioso, L., Claros, M. G., Viguera, E., Pajares, B., Sánchez, A., Ribelles, N., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091884 · Cited by 67
Evolutionary and Expression Analysis of miR-#-5p and miR-#-3p at the miRNAs/isomiRs Levels
Guo, L., Yu, J., Yu, H., Zhao, Y., Chen, S., Xu, C., & Chen, F. (2015) · BioMed Research International · doi:10.1155/2015/168358 · Cited by 33
Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
Singh, S., Saini, H., Sharma, A., Gupta, S., Huddar, V. G., & Tripathi, R. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1155254 · Cited by 25
Metadata
- Authors
- Yu, F., Deng, H., Yao, H., Liu, Q., Su, F., & Song, E.
- Venue
- Oncogene
- Published
- 2010-05-24
- Volume
- 29
- Issue
- 29
- Pages
- 4194-4204
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1983266682
- Cited by
- 301
- References
- 24
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
